Dilutional coagulopathy, an underestimated problem?;Die dilutionskoagulopathie, ein unterschätztes problem?

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 39, Issue 12, 2004, Pages 745-750

  Fries, Dietmar ^a   Streif, W ^b   Haas, T ^a   Kuhbacher C ^a  

^a Klin Anasthesie/Allg I   (Austria)

^b UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

Author keywords

Colloids; Crystalloids; Dilutional coagulopathy; Thrombelastography

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRIN; FIBRINOGEN; FRESH FROZEN PLASMA; HETASTARCH;

BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; COLLOID; CONFERENCE PAPER; CRYSTALLOID; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE CONCENTRATE; FIBRIN POLYMERIZATION; THROMBOELASTOGRAPHY;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; HEMODILUTION; HUMANS; REPRODUCIBILITY OF RESULTS; SODIUM CHLORIDE;

EID: 11244256380     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-825912     Document Type: Conference Paper

References (59)

1. Lynn M, Jeroukhimov I, Klein Y, Martinowitz U. Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med 2002; 28: 241-247
2. Kaufmann CR, Dwyer KM, Crews JD, Dois SJ, Trask AL. Usefulness of thrombelastography in assesment of trauma patient coagulation. J Trauma 1997; 42: 716-720
3. Cosgriff N, Moore EE, Sauaia A, Kenny-Moynihan M, Burch JM, Galloway B. Predicting life-threatening coagulopathy in massively transfused trauma patient: hypothermia and acidosis revisited. J Trauma 1997; 42: 857-862
4. Gando S, Tedo I, Kubota M. Post-trauma coagulation and fibrinolysis. Crit Care Med 1992; 20: 594-600
5. Kapsch DN, Metzler M, Harrington M, Mitchell FL, Silver D. Fibrinolytic response to trauma. Surgery 1984; 95: 473-478
6. Gubler KD, Gentilello LM, Hassantash SA, Maier RV. The impact of hypothermia on dilutional coagulopathy. J Trauma 1994; 36: 847-851
7. Murray DJ, Pennell BJ, Weinstein SL, Olson JD. Packed red cells in acute blood loss: dilutional coagulopathy as a cause of surgical bleeding, Anesth Analg 1995; 80: 336-342
8. Murray DJ, Olson J, Strauss R, Tinker JH. Coagulation changes during packed red cell replacement of major blood loss. Anesthesiology 1988; 69: 839-845
9. Leslie SD, Toy PTCY. Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloids. Am J Clin Pathol 1991; 96: 224-232
10. McLoughlinTM, FontanaJL, Alving B, Mongan PD, Bünger R. Profound normovolemic hemodilution: hemostatic effects in patients and in a porcine model. Anesth Analg 1996; 83: 459-465
11. Ciaverella D, Reed RL, Counts RB et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987; 67: 365-368
12. Gentillelo LM, Pierson DJ. Trauma critical care. Am J Respir Crit Care Med 2001; 163: 604-607
13. Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfused therapy and reexploration rate after institution of a blood management programm in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995; 9: 168-173
14. Whitten CW, Greilich PE. Thrombelastography: past, present and future. Anesthesiology 2000; 92: 1223-1225
15. Hartert H. Blutgerinnungsstudien mit der Thrombelastography, einem neuen Untersuchungsverfahren. Klein Wochenschr 1948; 16: 577-583
16. Mallet SV, Cox DJA. Thrombelastography. Br J Anaesth 1992; 69: 307-313
17. Haisch G, Boldt J, Krebs C et al. The influence of intravascular therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 2001; 92: 565-571
18. Calatzis AN, Kling M, Calatzis AL et al. Fast and specific coagulation monitoring through modified thrombelastography. Ann Hematol 1996; 72 (Suppl. 1): P92
19. Valeri CR, Cassidy G, Pivacek LE et al. Anemia induced increase in bleeding time: the implication for treatment of nonsurgical blood loss. Transfusion 2001; 41: 977-983
20. Small M, Lowe GD, Cameron E, Forbes CD. Contribution of the haematokrit to the bleeding time. Haemostasis 1983; 13: 379-384
21. Blajchman MA, Bordin JO, Bardossy L, Heddle NM. The contribution of the haematocrit to the thrombocytopenic bleeding in experimental animals. Br J Haematol 1994; 86: 347-350
22. Santos MT, Valles J, Aznar J et al. Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin. Circulation 1997; 95: 63-68
23. Peyrou V, Lormeau JC, Herault JP, Gaich C, Pfliegger AM, Herbert JM. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost 1999; 81: 400-406
24. Escolar G, Garrido M, Mazzara R, Castillo R, Ordinas A. Experimental basis for the use of red cell transfusion in the management of anaemic-thrombocytopenic patients. Transfusion 1988; 28: 406-411
25. Hiippala ST. Dextran and hydroxyethylstarch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995; 6: 743-746
26. Gottumukkala VNR, Sharma SK, Philip J. Assessing platelet and fibrinogen contribution to clot strength using modified thrombelastography in pregnant women. Anesth Analg 1999; 89: 1453-1455
27. Cochraine Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients. Systemic review of randomised controlled trials. BMJ 1998; 317: 235-240
28. Mortier E, Ongenae M, Baerdemaeker LD et al. In vitro evaluation of the effect of profound haemodilution with hydroxyethylstarch 6%, modified gelatine 4%, and dextran 40 10% on coagulation profile measured by thrombelastography. Anaesthesia 1997; 52: 1061-1064
29. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solution in critically ill patients: a systemic review of randomized trials. BMJ 1998; 316: 961-964
30. Choi P, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation. A systemic review. Crit Care Med 1999; 27: 200-221
31. Roberts I, Evans P, Bunn F, Kwan 1, Crowhurst E. Is the normalisation of blood pressure in bleeding trauma patients harmful? Lancet 2001; 357: 385-387
32. Ruttmann TG, James MFM, Viljoen JF. Haemodilution induces a hyper-coagulable state. Br J Anaesth 1996; 76: 412-414
33. Karoutsos S, Nathan N, Lahrimi A, Grouille D, Feiss P, Cox DJA. Thrombelastogramm reveals hypercoagulability after administration of gelatin solution. Br J Anaesth 1999; 82: 175-177
34. Ng KFJ, Lam CCK, Chan LC. In vivo effects of haemodilution with saline on coagulation: a randomized controlled trial. Br J Anaesth 2002; 88: 475-480
35. Ruttmann TG, James MFM, Finlayson J. Effects on coagulation of intravenous crystalloid or colloid in patients undergoing peripheral vascular surgery. Br J Anaesth 2002; 89: 226-230
36. Innerhofer P, Fries D, Klingler A, Streif W. In vivo effects of haemodilution with saline on coagulation. Br J Anaesth 2002; 89: 934-939
37. Fries D, Innerhofer P, Klingler A, Berresheim U, Mittermayr M, Calatzis A, Schobersberger W. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis. Anesth Analg 2002; 94: 1280-1287
38. Innerhofer P, Fries D, Margreiter J, Klingler A, Kühbacher C, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W. The effect of perioperatively administered colloids and crystalloids on primary hemostasis and clot formation. Anesth Analg 2002; 95: 858-865
39. Petroianu GA, Maleck WH, Koettner KP, Liu J, Schmitt A. Effect of in vitro hemodilution with hydroxyethylstarch and dextrans on the activity of plasma clotting factors. Crit Care Med 2003; 31: 250-254
40. Mardel SN, Saunders FM, Allen H et al. Reduced clot quality of clot formation with gelatin based plasma substitutes. Br J Anaesth 1998; 80: 204-207
41. Engvall E, Ruoslahti E, Miller EJ. Affinity of fibronectin to collagens of different genetic types and fibrinogen. J Exp Med 1978; 147: 1584-1595
42. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Int Care Med 1999; 75: 258-268
43. Vogt NH, Bothner U, Lerch G, Lindner KH, Georgieff M. Large dose administration of 6% hydroxyethyl starch 200/0.5 for total hip arthroplasty: plasma homeostasis, hemostasis and renal function compared to use of 5% human albumin. Anesth Analg 1996; 83: 262-268
44. Entholzer EK, Mielke LL, Calatzis AN, Feyh J, Hipp R, Hargamer SR. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand 2000; 44: 1116-1121
45. Gallandat R, Siemons A, Baus D et al. A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anesth 2000; 47 (12): 1207-1215
46. Menzebach A, Cassens U, Van Aken H, Booke M. Strategies to reduce perioperative blood loss related to non surgical bleeding. Eur J Anaesthesiol 2003; 20: 764-770
47. Mortelsmans YJ, Vermaut GA, Van Aken H. A simple method for calculating component dilution during fluid resuscitation: the Leuven approach. J Clin Anesth 1994; 6: 279-287
48. Stainsby D, MacLennan S, Hamilton PJ. Management of massive blood loss: a template guideline. Br J Anaesth 2000; 85: 487-491
49. Reed RL, Ciavgerella D, Heimbach DM et al. Prophylactic platelet administration during massive transfusion. Ann Surg 1986; 203: 40-48
50. Hirshberg A, Dugas M, Banez EI, Scott BG, Wall MJ, Mattox KL Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 2003; 54: 454-463
51. Hiippala ST, Myllylä GJ, Vantera EM. Hemostatic factors and replacement of major blood loss with plasma poor red cell concentrates. Anesth Analg 1995; 81: 360-365
52. Murray DJ, Pennel BJ, Weinstein SL, Olson JD. Packed red cells in acute blood loss: dilutional coagulopathy as a cause of surgical bleeding. Anesth Analg 1995; 80: 336-342
53. Eika C, Havie O,Godal HC The value of preoperative haemostatic screening. Scand J Haematol 1978; 21: 349-354
54. Robbins JA, Rose SD. Partial thromboplastin time as screening test. Ann Intern Med 1979; 90: 796
55. Lucas CE, Ledgerwood AM. Clinical significance of altered coagulation tests after massive transfusion for trauma. Ann Surg 1981; 47: 125-130
56. Singbartl K, Innerhofer P, Radvan J et al. Hemostasis and hemodilution: a quantitative mathematical guide for clinical practice. Anesth Analg 2003; 96: 929-935
57. Vorstand und wissenschaftlicher Beirat der Bundesärztekammer. Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. Köln: Deutscher Ärzteverlag, 2001
58. Savirez M, Fries D, Klingler A, Schobersberger W, Innerhofer P. The effect of the fibrinogen and factor XIIl substitution on dilutional coagulopathy - an in vitro model using thrombelastography (ROTEG). Annals of Hematology 2002; 81 (Suppl. 1): P76
59. Fries D, Krismer A, Schobersberger A, Klingler A, Klima G, Wenzel V, Innerhofer P. The effect of fibrinogen on dilutional coagulopathy - a porcine model. Intensive Care Medicine 2003; 29 (Suppl. 1): D527